Background: Antibiotic resistance emerged as clinical problem challenge the effective treatment of infections. Virulence factor may play an important role in the influence of antimicrobial resistance. Objective: To determine the frequency of resistance gene in E. coli clinical isolates from women with urinary tract infection. Materials and Methods: Fifteen E.coli clinical isolates were tested by PCR to determine their molecular characterization.
Material and Methods: Study Population.
A prospective cross-sectional study was conducted during the period from 1 st of June 2015 to the end of January 2016. The population included in the study were 563 women, of them 425 (75.5%) were outpatients and 138 (24.5%) were inpatients. Their age range between 18 and 80 years, with a mean age of 33.59±15.29 years. The study proposal was approved by the Ethical Committee of College of Science, Tikrit University and verbal informed consent taken from each woman before enrolment in the study. Fifteen clinical E. coli isolates were included in the study of the molecular characterization of the isolates, of them 5 isolates were collected from students, 5 from diabetic women and 5 from pregnant women. PCR Biological materials Enzymes: Proteinase K: This enzyme was provided by Bio basic Inc. Taq DNA polymerase: It was provided from Bio labs Company-England . DNA extraction kit: Bio Basic Inc (Canada) Molecular DNA Marker (100bp and 10 kb DNA ladder): It was purchased from New England Bio labs Inc. Primers: These primers were provided by TIB MOLBIOL Company (Syntheses labor GmbH Eerburgstra Be -Berlin -Germany). Four primers were used in this study. These primers and their sequences are listed in Table (1) . Bacteria Collection and DNA extraction Genomic DNA from E.coli was isolated by using Genomic DNA Kit. The number of bacteria was appropriated and spined at 8,000 rpm for 5 minutes at room temperature. Then was removed supernatant completely and discarded then resuspended in 200 μl cold TE buffer. Four hundred μl Digestion Solution was added to 200 μl sample from (step1) mixed well then added 3 μl proteinase K solution and incubate at 55 ºC for 5 minutes to obtained complete listed. Then 260 μl of 100 % ethanol was added to the same solution and mixed well. The mixture applied into the column that is in a 2.0 ml collection tube .Then spined at 8,000 rpm for 1minute. The flow-through discard in the collection tube. Added 500 μl of Wash solution, and spined at 8,000 rpm for 1minute. Repeated washing. The flow -through discard and spined at 1,000 rpm for an additional minutes to remove residual amount of wash solution. The EZ-10 column Placed into a clean 1.5 ml microfuge tube. Added 30-50 μl elution buffers into the center part of membrane in the column. Incubated the tube at 55 ºC for 2 minutes. The column spined at 1,000 rpm for 1minute to elute DNA quantity was Measured by UV absorption at A260 (1.0 OD unit is equivalent of 50 μg).
Spectrophotometric Estimation of DNA
The DNA samples were diluted 100 times with TE buffer. The optical density (OD) of each sample was read at wave length of (260 & 280 nm) with a spectrophotometer. The DNA concentration in the solutions was calculated according to the following formula: -DNA concentration (μg /μl) = [OD260*100*50 μg/ml] /1000 Since, OD260 is optical density of DNA at 260 nm, 100 is the dilution factor, and 50 μg/ml is amounted of double stranded DNA when OD at 260 nm is1.The purity of DNA was estimated depending on the ratio of OD260/ OD280. This ratio for pure DNA is (1.6-1.8) [13] . Preparation the PCR Master Mix. . The optimization of parameter for PCR assay was carried out according to Table (1) , four primers were used. Table ( 2) shows the components required for PCR reaction. Taq buffer, MgCl2, dNTPS, primer solution and template DNA were thawed, mixed by vortex, and placed on ice..For optimization of each parameter, a master mix of all the reagents was stated above, and the reagent which assayed individually was added. The PCR master mix was poured in to Eppendorf tubes, mixed by vortex and it was completed to 50 μl by adding sterile distilled water, and then placed inside thermal machine. PCR amplification cycles for virulence factors as shown in Table ( 3). 
Agarose Gel Electrophoresis
Agarose gels (0.7%) was made by adding o.7 gm of agarose to 100 ml of 1X TBE buffer solubiliezed by heating at boiling temperature, then the agarose was left to cool at 55 o C before pouring in a plastic plate to solidify. A comb was placed near one edge of gel, and the gel was left to harden. 1XTBE was poured into gel tank and the gel plate was placed horizontally in electrophoresis tank, 3μl of loading buffer was mixed with 2ml DNA samples, and then samples were added carefully to individual wells. [13] agarose gels were stained with ethidium bromide by immersing them in D.W containing the dye of final concentration of 0.5μg/ml for 30-45 minute.
.
Statistical Analysis.
The data presented as percentages and means according to their appropriateness. Statistical analysis was performed using SPSS package [version 20] .Chi square was used to calculate significance for frequency, while t test used to determine significance in mean difference. Multiple antibiotic resistance index [MARI] calculated by dividing the number of resistance isolates antibiotic to the total tested isolates [14] . While multidrug resistance value was considered when the isolates were resistant to more/ equal to 3 antibiotics belong to different antimicrobial agents group.
Results:
The bla CTX -M gene was not detected in 1 (6.7%) out of the tested 15 E. coli clinical isolates from women with urinary tract infection. This bla CTX-M negative E. coli isolate was from diabetic women with UTI. All the positive isolates demonstrated a single band with 600 bp. All E. coli isolates from female student and pregnant women were bla CTX-M positive, 
Figure (1). Molecular detection of bla CTX-M antibiotic resistance genes.PCR amplification of bla CTX-M gene in E coli
The bla OXA gene was detected in all E. coli tested clinical isolates from pregnant women, female student and diabetic women with urinary tract infection. The isolates show 1 to 3 band, 60% [9/15] 
Figure(2). Molecular detection of bla -OXA antibiotic resistance genes. PCR amplification of bla-Oxa gene in E coli
The bla TEM gene was not detected in 5 (33.3%) out of 15 tested E. coli clinical isolates. The bla TEM gene negative isolates was 1 (6.7%) from female student, 2 (13.4%) from diabetic women, and 2 (13.4%) from pregnant women. The bla TEM gene positive isolates were 9 (60%) with single band and 1 (6.7%) with double band, (500-800 bp), Fig(3) and Table( 
PCR amplification of bla-TEM gene in E coli
The bla SHV gene was not detected in 40% [6/15] of the E. coli tested isolates. Of the total 6 negative isolates, 2 [13.4%] were from female student, 
Figure (4). Molecular detection of bla SHV antibiotic resistance genes. PCR amplification of bla-HSV gene in E coli
The frequency of combination was 6.67% for CTX-M with OXA; TEM with OXA, and OXA, TEM with SHV. While combination of CTX-M, OXA with TEM forms 26.67%, however, CTX-M, OA with SHV also forms 26.67%. The four gene combination accounted for 26.67% and this finding demonstrated 6 trends of gene combination, Table ( 2).
The higher frequency rate of E. coli antibiotic resistance gene was demonstrated by bla-OXA gene (100%; 15/15), followed by bla CTX-M gene [86.7%, 13/15], and bla-TEM gene (66.7%, 10/15), while the lowest one was bla SHV gene which detected in 60% (9/15) of the isolates. In addition, higher number of band were demonstrated by bla OXA gene, which was 21 band in 15 positive isolate (ratio =1.4), 13 band in 13 positive bla CTX-M gene positive isolate (ratio=1), 10 band in 10 bla TEM positive isolate (ratio=1), and 9 band in 9 bla SHV positive isolate (ratio=1), 16 antibiotics, 2 of them were positive for bla CTX-M, bla OXA and bla TEM genes and negative for bla SHV gene. However, the 3rd isolate that was resistant to 16 antibiotics was positive for the 4 genes. Thus the higher rate of multiple antibiotic resistance were demonstrated in E. coli isolated that were positive for bla CTX-M and bla OXA genes, however, there was no specific trend of positivity association with multiple antibiotic resistance, Table ( 3). [16, 17] . Numerous studies, CTX-M ESBL producing E. coli emerged as an aetiology of community acquitted UTI in India, Hong Kong, Europe, USA and Japan [15, [18] [19] [20] [21] . Lartigue et al. [22] , France, found that 1/3 of ESBL positive EC were CTX-M genotype [CTX-M-3, CTX-M-10, CTX-M-14 and CTX-M-15] in clinical isolates from hospitals located in Paris, however, during the same period, other studies reported that 90% of ESBL positive were CTX-M-3 CTX-M-24 in isolates from hospital outside Paris [23, 24] . Other two studies reported that CTX-M-15 was the predominant ESBL genotype in other hospital in France and UK [19, 25] .
Dallenne et al [26] , In France, it was found that CTX-M-15genotype of ESBL E coli was the predominant; however, CTX-M-1 and CTX-M-9 were also detected. [27] , China, reported that ESBL CTX-M genotype form 42.34% of the total isolates and 33.3% were CTX-M-14 and 10.8% were CTX-M-15 type. Yazdi et al., [28] , Turkey, found that 68.8% of ESBL producer E. coli isolates were carrying CTX-M genotype. Harada et al., [29] , Japan reported that ESBL positive E. coli carrying CTX-M genotype in 25% of their tested isolates, in particular CTX-M-9 group. Kang et al., [30] , Korea, study shows that CTX-M was predominant and form 76.7% in ESBL producer E. coli. Ludden et al. [31] , Ireland, found that 97% of ESBL producer E. coli isolates harboured CTX-M genotype. Another study from Korea [32] showed that 90% of ESBL producing E. coli were of CTX-M genotype. In Iraq, previous studies indicated that CTX-M gene was the most frequently detected in ESBL E. coli isolates [33] [34] [35] .
The bla OXA gene was detected in all E coli tested clinical isolates from pregnant women, female student and diabetic women with urinary tract infection. The isolates show 1 to 3 bands, 60% (9/15) show single band, 13.3% (2/15)show double band, and 20% (3/15) show 3 bands, with 170 to 900 bp. In addition, the bla TEM gene was detected in 10 (66.7%) out of 15 tested Ecoli clinical isolates. The bla TEM gene negative isolates was 1 (6.7%) from female student, 2 (13.4%) from diabetic women, and 2 (13.4%) from pregnant women. The bla TEM gene positive isolates were 9 [60%] with single band and 1 (6.7%) with double band, (500-800 bp). Furthermore, the bla SHV gene was not detected in 40% (6/15) of the EC tested isolates. Of the total 5 negative isolates, 2 (13.4%) were from female student, 3 (20%) from diabetic women and 1 (6.7%) from pregnant women. The entire bla SHV gene was with single band (759 bp). Thus present study data indicated that OXA gene demonstrated in 100% of ESBL E. coli uropathogenic isolates tested in this study, while TEM gene presented in 66.7% of the isolates and 60% were harbouring SHV gene. Previous studies reported variable gene frequencies, 76% for OXA in Ireland [31] , while TEM gene reported in 86.24% of E. coli ESBL isolates in Turkey [28] , 40% in Japan [29] , 34% in Ireland [31] , 16 .81% in Iran [36] , 10% in Iraq [33] , 5% in Kenya [37] , and 0.9% in Japan [15] . But TEM genotype was found in 80% of E. coli ESBL isolates in Japan [29] , 72.23% in Turkey [28] , 12.1% in Iran [36] , 3.33% south Korea [32] , 3% in Ireland [31] , 3% in Kenya [37] and 2.8% in Japan [15] .
The above frequencies varies with geographical areas of the performed studies, however, the global trends indicated an increase of CTX-M gene in ESBL E. coli isolates and became responsible for outbreak of community and hospital acquired UTI infection [15, 22, [38] [39] [40] [41] [42] [43] . The higher frequency rate of E. coli antibiotic resistance gene was demonstrated by bla -OXA gene (100%; 15/15), followed by bla CTX-M gene (86.7%, 13/15), and bla-TEM gene (66.7%, 10/15), while the lowest one was bla SHV gene which was detected in 60% (9/15) of the isolates. In addition, higher number of band were demonstrated by bla OXA gene, which was 21 band in 15 positive isolate [ratio =1.4], 13 bands in 13 positive bla CTX-M gene positive isolate (ratio=1), 10 bands in 10 bla TEM positive isolate (ratio=1), and 9 band in 9 bla SHV positive isolate (ratio=1). Multiple antibiotic resistance rates ranged from 9 to 17 antibiotics from 22 tested panels (40.9%-77.27%). The EC isolates that demonstrated resistance to 17 antibiotics was positive for bla CTX-M, bla OXA and bla TEM genes and negative for bla SHV gene. While the isolates that demonstrated resistance to 16 antibiotics, 2 of them were positive for bla CTX-M, bla OXA and bla TEM genes and negative for bla SHV gene. However, the 3rd isolate that was resistant to 16 antibiotics was positive for the 4 genes. Thus the higher rate of multiple antibiotic resistance were demonstrated in E. coli isolates that were positive for bla CTX-M and bla OXA genes, however, there was no specific trend of positivity association with multiple antibiotic resistance. respectively. Thus, the tested isolates were with MDR to antimicrobials from more than 5 antibiotics groups who harbour CTX-M, OXA and SHV , while those with TEM genes were with multidrug resistance to antibiotics belong to more than 6 antimicrobial groups. The mean MDR of TEM, CTX-M and SHV positive E. coli isolates were significantly higher than those TEM, CTX-M and SHV negative isolates. In addition, when the analysis performed on individual antibiotic strata it indicated that the frequency of resistance rate to antibiotics between bla CTX-M , bla TEM and bla SHV genes positive E. coli and those negative isolates indicated differences. Thus the present study findings illustrated an association between frequency, MARI and MDR and carrying of the isolates for TEM, CTX-M and SHV as compared to non-harbouring isolates.
The frequency of combination was 6.67% for CTX-M + OXA; TEM + OXA, and OXA + TEM + SHV. While combination of CTX-M + OXA + TEM form 26.67%, and CTX-M + OXA + SHV also form 26.67%, the four gene combination accounted for 26.67%. Thus this study finding demonstrated a 6 trends of gene combination and none of the 15 tested E. coli isolates harbouring a single gene. Harada et al., [29] , Japan, found that the predominant genotype was CTX-M + TEM which forms 48.3% for E. coli. Single TEM or SHV or CTX-M accounted for 8.1%, 3.1% and 28.2% respectively, while TEM+SHV genotypes form 1.3% and CMX-M + SHV genotypes form 0.6%. Presence of more than gene in the same isolates was reported in literature and previous studies reported that co-existence of CTX-M and TEM is the predominant combination in studies performed in Iran, India and Saudi Arabia. [44] which contrasted with the present study finding.
In the present study four types of ESBL genes were detected, and shows new trend of distribution, which indicated the predominance of OXA and CTX-M genes. The high rate of CTX-M genotype was consistent with that reported for Iran (74%) [44] , Lithuania (96%) [45] , Portugal (76%) [46] , and Turkey (83.18%) [47] . However, other studies reported the predominance of TEM genotype of ESBL in Turkey (72.7%) [48] , Sweden (63%) [49] , Italy (45.4%) [50] and Portugal (40.9%) [51] , which lower to the present study finding (66.7%). SHV genotype detected in 60% of E. coli isolates tested in this study, which was higher to the rate reported for India (57.5%) [52] , Iran (45%) [44] , Saudi Arabia (23.1%) [53] , Turkey (9.09%) [48] , Sweden (6%) [49] and Thailand (3.8%) [54] , which contracted with the present study findings.
In a recent study in Iraq [55] , reported that 93.3% of their patients with recurrent UTI were with multidrug resistance, however, their interpretation represent multiple antibiotic resistance rate rather than multidrug resistance rate. Our MDR rate was 55.95% in ESBL producer E. coli and was 62.1% in ESBL negative E. coli isolates. Daoud et al., [56] , In Lebanon, it was found that ESBL CTX-M gene present in 100% of the tested isolates, while TEM present in 68.2%, SHV in 30.7% and OXA in 29.6%. In contrast, our study indicated that OXA harbored by E. coli in 100% of the isolates, followed by CTX-M in 93.3%, TEM in 66.7% and SHV in 60%, a trend which was different from that for Lebanon. In addition, 26.67% of the E. coli isolates carrying 4 genes, which was higher to that reported by others as the corresponding value was 15.9% [56] .
Another study performed in Libya showed that OXA was found in 76.9% of E. coli urinary isolates, TEM in 53.8%, and CTX-M in 46.2% [57] . While, Bourjilat et al ., [58] , Casablanca, Morocco, found that CTX-M genes in 85.7% of isolates collected during 2004 -2007.
Shi et al [59] , China, found that TEM ESBL genotype was with a range of 63.2% to 96.7% in 5 hospitals, while OXA with a range of 10.5% -33.3% and overall rate of 21.5% in the five hospitals, but SHV was with a range of 0% -30% and overall rate of 17.7%. In Sweden, OXA ESBL gene accounted for 59%, while SHV was detected in only 6% of ESBL producer E. coli isolates [49] .
Potron et al [60] , studied the spread of OXA ESBL Enterobacteriaceae and concluded that this gene spread through single plasmid and identified multiple cases of importation of OXA-48 ESBL in Europe and gene endemicity in France. North African and Middle East countries are reservoirs of OXA-48 ESBL gene [61] . OXA-48 ESBL gene firstly in K. pneumonia in Turkey in 2001 and later in E. coli in Turkey in 2010 [62, 63] and detected for several years in Turkey only and in hospital setting [63] . However, in the present study E. coli harbouring OXA ESBL was from community and hospital acquired infections and not confined mainly to inpatients as mentioned above.
ESBL producers E. coli isolates have become public health problems due to its role as a cause of UTI with the emergence of new trends of ESBL genes such as CTX-M and OXA in both hospital and community acquired infections [64, 65] . In Lebanon, [66] , found that CTX-M, OXA, TEM, and SHV ESBL genes were detected in rate of 98.6%, 45.2%, 21.9% and 4.1% respectively in E. coli ESBL producers isolates. In addition, the co-existence of CTX-M+TEM form 8.2%, CTX-M + OXA form 30.14%, CTX-M+SHV form 2.74%, CTX-M+OXA+TEM form 12.33%, and CTX-M+OXA+TEM+SHV form 1.37%, while CTX-M alone form 43.8% and OXA form 1.37%. However, the present study shows only 3 comparable combination, CTX-M +OXA form 6.67%, while in Sana et al [66] study form 30.14%; while CTX-M+OXA+TEM form 26.67% in our cohort and 12.33% in Sana study, and the combination of 4 genes from 26.67% in our study and 1.37% in Sana study.
Almayahie and Alkuraishy [55] in a recent study in Iraq, reported that CTX-M ESBL gene was detected in 70.3% of E. coli isolates, while OXA gene present in 32.9%, SHV in 10.9% and TEM was not detected in any isolate. Co-existence of genes was found in two forms, the SHV+CTX-M (6.5%) and OXA+CTX-M (32.9%). In the present study, the CTX-M +OXA gene combination with rate of 6.67%, which is much lower to that of Almayahie and Alkuraishi, [55] , but others co-existence pattern in our study was not reported by them.
The E. coli bla TEM producer isolates were detected in 66.7% of the tested clinical isolates from women with urinary tract infection, and was higher to that reported in Sweden (63%) [49] . The EC bla TEM positive isolates were 60% from each of pregnant and diabetic women groups, while 80% from female student group.
The global distribution of E. coli ESBL genes varied between different studies, however, in general the CTX-M gene emerged after SHV and TEM , but now was the predominant worldwide [22, 39, 40, 49, 65, [67] [68] [69] [70] [71] [72] [73] . In the present study CTX-M accounted for 93.3% of E. coli ESBL producer isolates, while OXA gene was the predominant gene. The predominance of OXA gene harbouring is firstly reported in this study. In conclusion, the OXA ESBL gene was detected in all tested E. coli isolates followed by CTX-M gene [93.3%], TEM [66.7%] and SHV [60%] and the presence of these genes significantly influenced the emergence of antibiotic resistance of the tested isolates.
